CBD Life Sciences, Inc. (CBDL) Launches First-of-Its-Kind CBD Horse Paste: A Veterinarian-Designed Solution for Equine Wellness
The annual economic impact of the equine industry is significant - involving some $300 billion dollars and 1.6 million full-time jobs. CBD Life Sciences' Groundbreaking...
CBD Life Sciences Inc. (CBDL) Ignites Expanding Revenue Stream With RangeMe, Poised for Explosive Growth
RangeMe connects CBDL to over 200,000 retail buyers, including some of the world's largest retailers, driving exponential market opportunitiesCBD Life Sciences Inc. (OTC PINK:CBDL), a...
CBD Life Sciences Inc. (CBDL) Targets Amazon Marketplace for Strategic Business Enhancements
With Amazon's market value increasing by more than $400 billion in 2024, CBD Life Sciences Inc. is poised for new revenue growth with top-selling CBD...
CBD Life Sciences Inc. (CBDL) Announces Record Revenue Increase of 1405.46% Since February 2024
The U.S. CBD consumer health market size was estimated at USD 7.81 billion in 2023 and is projected to surpass around USD 31.11 billion by...
CBD Life Sciences, Inc. (CBDL) Announces Expanding Revenue Stream With Walmart Marketplace
Walmart's market cap as of September 2024 is $635.50 billion, making it the 13th most valuable company in the world. This partnership offers CBD Life...
CBD Life Sciences, Inc. Unveils Groundbreaking Nutritional Supplement Infused With Mushroom Extracts, Set to Drive Revenue and Revolutionize Wellness
Projected to increase company revenue by 20% in the first year, capitalizing on the booming $18 billion wellness market.CBD Life Sciences, Inc. (CBDL), an innovative...
CBD Life Sciences, Inc. (CBDL) Unveils Mellow Mornings: A Revolutionary Nano CBD Coffee Creamer Set to Boost Revenue Amid Growing National Demand
CBD Life Sciences, Inc. (OTC PINK:CBDL), a leader in the CBD industry, is excited to announce the launch of its latest innovation, Mellow Mornings, a...
CBD Life Sciences, Inc. (CBDL) Announces MOU With New York Dispensary, Poised for Significant Revenue Growth and Shareholder Value
The targeted acquisition is estimated to have a business value of approximately $10 million and projected 2024 gross revenues of up to $4.5 millionCBD Life...
CBD Life Sciences, Inc. Expands Footprint With Proposed Strategic Acquisition of Interest in Two New York Cannabis Dispensaries
The targeted acquisitions are estimated to have a business value of approximately $14 millionCBD Life Sciences, Inc. (OTC PINK:CBDL), a leading innovator in the CBD...
Why Novus Doesn’t Need SAFE Banking Act To Grow Revenue
Novus' CEO Gives Exclusive Interview with Health Leaders MediaMIAMI, FL / ACCESSWIRE / January 10, 2023 / Novus Acquisition and Development, Corp. (OTC Markets:NDEV), through...